DNA 합성기 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

DNA Synthesizer Market Summary

The global DNA synthesizer market size was valued at USD 334.7 million in 2025 and is projected to grow from USD 382.0 million in 2026 to USD 1,032.7 million by 2033, at a CAGR of 15.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.3% in 2025. The increasing demand for efficient DNA synthesizers from life science laboratories, and pharmaceutical & biotechnology companies is the major factor driving the market.

Global DNA Synthesizer Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global DNA synthesizer market based on type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Benchtop DNA Synthesizers
• Large-scale DNA Synthesizers
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug Discovery & Development
• Genetic Engineering
• Clinical Diagnostics
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Clinical Laboratories
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Type
  • 1.2.2. Application
  • 1.2.3. End use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Impact Analysis
    • 3.3.1.1. Growing demand for synthetic biology & gene editing
    • 3.3.1.2. Technological advancements in DNA synthesis & advances in the field of synthetic biology
    • 3.3.1.3. Increasing demand for personalized medicine & gene therapies
  • 3.3.2. Market Restraint Impact Analysis
    • 3.3.2.1. Stringent regulations and ethical concerns
  • 3.3.3. Market Opportunity Impact Analysis
  • 3.3.4. Market Challenge Impact Analysis
• 3.4. Case Study Insights
• 3.5. Industry Analysis Tools
  • 3.5.1. Porter's Analysis
    • 3.5.1.1. Bargaining power of the suppliers
    • 3.5.1.2. Bargaining power of the buyers
    • 3.5.1.3. Threats of substitution
    • 3.5.1.4. Threats from new entrants
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Economic and Social landscape
    • 3.5.2.3. Technological landscape
    • 3.5.2.4. Environmental landscape
    • 3.5.2.5. Legal landscape

Chapter 4. Type Business Analysis

• 4.1. Type Segment Dashboard
• 4.2. Global DNA Synthesizer Market Type, Movement Analysis
• 4.3. Global DNA Synthesizer Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Benchtop DNA Synthesizers
  • 4.4.1. Benchtop DNA synthesizers market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Large-scale DNA Synthesizers
  • 4.5.1. Large-scale DNA synthesizers market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Application Segment Dashboard
• 5.2. Global DNA Synthesizer Market Application, Movement Analysis
• 5.3. Global DNA Synthesizer Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Drug Discovery & Development
  • 5.4.1. Drug discovery & development market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Genetic Engineering
  • 5.5.1. Genetic engineering market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Clinical Diagnostics
  • 5.6.1. Clinical diagnostics market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. End Use Segment Dashboard
• 6.2. Global DNA Synthesizer Market End Use, Movement Analysis
• 6.3. Global DNA Synthesizer Market Size & Trend Analysis, By End Use, 2021 to 2033 (USD Million)
• 6.4. Academic & Research Institutes
  • 6.4.1. Academic & Research Institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Pharmaceutical & Biotechnology Companies
  • 6.5.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Clinical Laboratories
  • 6.6.1. Clinical laboratories market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. DNA Synthesizer Market: Regional Estimates and Trend Analysis, by Type, Application, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. U.S. DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Canada DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Mexico DNA synthesizer market, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. UK DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Germany DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. France DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Italy DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Framework
    • 7.4.6.4. Spain DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Denmark DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Framework
    • 7.4.8.4. Sweden DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Framework
    • 7.4.9.4. Norway DNA synthesizer market, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Japan DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. China DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. India DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.5.5. Singapore
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Singapore DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Australia DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Thailand DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.5.8. South Korea
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. South Korea DNA synthesizer market, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Brazil DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Argentina DNA synthesizer market, 2021 - 2033 (USD Million)
• 7.7. MEA
  • 7.7.1. MEA DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. South Africa DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Saudi Arabia DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. UAE DNA synthesizer market, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Kuwait DNA synthesizer market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position/Share Analysis, 2025
• 8.4. Company Profiles/Listing
  • 8.4.1. Danaher Corporation
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Twist Bioscience
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. K&A Labs GmbH (acquired by Sierra BioSystems)
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. LGC Limited
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. CSBio
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Elegen Corporation
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. DNA Script
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. OligoMaker APS
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. PolyGen Gmbh
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Biolytic Lab Performance Inc.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. Evonetix
    • 8.4.11.1. Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Product Benchmarking
    • 8.4.11.4. Strategic Initiatives